APO Research
Talk to an analyst

APO RESEARCH · REPORT

Gene Delivery System Technology Drug

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Gene Delivery System Technology Drug Market Analysis and Forecast 2026-2032

2 January 2026193 pages

Choose your research edition.

Industry ResearchGene Delivery System Technology Drug Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Gene Delivery System Technology Drug Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Gene Delivery System Technology Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Gene Delivery System Technology Drug Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Gene Delivery System Technology Drug Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Gene Delivery System Technology Drug market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Gene Delivery System Technology Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Gene Delivery System Technology Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Gene Delivery System Technology Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Gene Delivery System Technology Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Gene Delivery System Technology Drug include Akcea Therapeutics, Alnylam Pharmaceuticals, AnGes, bluebird bio, Gilead Sciences, Human Stem Cells Institute, Orchard Therapeutics, Sarepta Therapeutics and SIBIONO, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Gene Delivery System Technology Drug, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Gene Delivery System Technology Drug, also provides the revenue of main regions and countries. Of the upcoming market potential for Gene Delivery System Technology Drug, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Gene Delivery System Technology Drug revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Gene Delivery System Technology Drug market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Gene Delivery System Technology Drug revenue, projected growth trends, production technology, application and end-user industry.

Gene Delivery System Technology Drug Segment by Company

Akcea Therapeutics

Alnylam Pharmaceuticals

AnGes

bluebird bio

Gilead Sciences

Human Stem Cells Institute

Orchard Therapeutics

Sarepta Therapeutics

SIBIONO

Spark Therapeutics

Sunway Biotech

Amgen

Biogen

Novartis

Gene Delivery System Technology Drug Segment by Type

Viral Gene Delivery System

Non-viral Gene Delivery System

Gene Delivery System Technology Drug Segment by Application

Neurological Diseases

Cancer

Other

Gene Delivery System Technology Drug Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Gene Delivery System Technology Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Gene Delivery System Technology Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Gene Delivery System Technology Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Gene Delivery System Technology Drug in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Gene Delivery System Technology Drug company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Gene Delivery System Technology Drug revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Gene Delivery System Technology Drug Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Viral Gene Delivery System Major Player Table 3. Non-viral Gene Delivery System Major Player Table 4. Global Gene Delivery System Technology Drug Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Neurological Diseases Major Player Table 6. Cancer Major Player Table 7. Other Major Player Table 8. Gene Delivery System Technology Drug Industry Trends Table 9. Gene Delivery System Technology Drug Industry Drivers Table 10. Gene Delivery System Technology Drug Industry Opportunities and Challenges Table 11. Gene Delivery System Technology Drug Industry Restraints Table 12. Global Gene Delivery System Technology Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 13. Global Gene Delivery System Technology Drug Market Size by Region (2021-2026) & (US$ Million) Table 14. Global Gene Delivery System Technology Drug Market Share by Region (2021-2026) Table 15. Global Gene Delivery System Technology Drug Market Size by Region (2027-2032) & (US$ Million) Table 16. Global Gene Delivery System Technology Drug Market Share by Region (2027-2032) Table 17. Global Gene Delivery System Technology Drug Revenue by Players (US$ Million) & (2021-2026) Table 18. Global Gene Delivery System Technology Drug Revenue Market Share by Players (2021-2026) Table 19. Global Gene Delivery System Technology Drug Key Players Ranking, 2024 VS 2025 VS 2026 Table 20. Global Gene Delivery System Technology Drug Key Players Headquarters & Area Served Table 21. Global Gene Delivery System Technology Drug Players, Product Type & Application Table 22. Global Gene Delivery System Technology Drug Players Establishment Date Table 23. Global Players Market Concentration Ratio (CR5 and HHI) Table 24. Global Gene Delivery System Technology Drug by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 25. Global Gene Delivery System Technology Drug Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Gene Delivery System Technology Drug Revenue by Type (2021-2026) & (US$ Million) Table 27. Global Gene Delivery System Technology Drug Revenue by Type (2027-2032) & (US$ Million) Table 28. Global Gene Delivery System Technology Drug Revenue Market Share by Type (2021-2026) Table 29. Global Gene Delivery System Technology Drug Revenue Market Share by Type (2027-2032) Table 30. Global Gene Delivery System Technology Drug Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Gene Delivery System Technology Drug Revenue by Application (2021-2026) & (US$ Million) Table 32. Global Gene Delivery System Technology Drug Revenue by Application (2027-2032) & (US$ Million) Table 33. Global Gene Delivery System Technology Drug Revenue Market Share by Application (2021-2026) Table 34. Global Gene Delivery System Technology Drug Revenue Market Share by Application (2027-2032) Table 35. Akcea Therapeutics Company Information Table 36. Akcea Therapeutics Business Overview Table 37. Akcea Therapeutics Gene Delivery System Technology Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Akcea Therapeutics Gene Delivery System Technology Drug Product Portfolio Table 39. Akcea Therapeutics Recent Development Table 40. Alnylam Pharmaceuticals Company Information Table 41. Alnylam Pharmaceuticals Business Overview Table 42. Alnylam Pharmaceuticals Gene Delivery System Technology Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Alnylam Pharmaceuticals Gene Delivery System Technology Drug Product Portfolio Table 44. Alnylam Pharmaceuticals Recent Development Table 45. AnGes Company Information Table 46. AnGes Business Overview Table 47. AnGes Gene Delivery System Technology Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. AnGes Gene Delivery System Technology Drug Product Portfolio Table 49. AnGes Recent Development Table 50. bluebird bio Company Information Table 51. bluebird bio Business Overview Table 52. bluebird bio Gene Delivery System Technology Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. bluebird bio Gene Delivery System Technology Drug Product Portfolio Table 54. bluebird bio Recent Development Table 55. Gilead Sciences Company Information Table 56. Gilead Sciences Business Overview Table 57. Gilead Sciences Gene Delivery System Technology Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Gilead Sciences Gene Delivery System Technology Drug Product Portfolio Table 59. Gilead Sciences Recent Development Table 60. Human Stem Cells Institute Company Information Table 61. Human Stem Cells Institute Business Overview Table 62. Human Stem Cells Institute Gene Delivery System Technology Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Human Stem Cells Institute Gene Delivery System Technology Drug Product Portfolio Table 64. Human Stem Cells Institute Recent Development Table 65. Orchard Therapeutics Company Information Table 66. Orchard Therapeutics Business Overview Table 67. Orchard Therapeutics Gene Delivery System Technology Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Orchard Therapeutics Gene Delivery System Technology Drug Product Portfolio Table 69. Orchard Therapeutics Recent Development Table 70. Sarepta Therapeutics Company Information Table 71. Sarepta Therapeutics Business Overview Table 72. Sarepta Therapeutics Gene Delivery System Technology Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. Sarepta Therapeutics Gene Delivery System Technology Drug Product Portfolio Table 74. Sarepta Therapeutics Recent Development Table 75. SIBIONO Company Information Table 76. SIBIONO Business Overview Table 77. SIBIONO Gene Delivery System Technology Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. SIBIONO Gene Delivery System Technology Drug Product Portfolio Table 79. SIBIONO Recent Development Table 80. Spark Therapeutics Company Information Table 81. Spark Therapeutics Business Overview Table 82. Spark Therapeutics Gene Delivery System Technology Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. Spark Therapeutics Gene Delivery System Technology Drug Product Portfolio Table 84. Spark Therapeutics Recent Development Table 85. Sunway Biotech Company Information Table 86. Sunway Biotech Business Overview Table 87. Sunway Biotech Gene Delivery System Technology Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 88. Sunway Biotech Gene Delivery System Technology Drug Product Portfolio Table 89. Sunway Biotech Recent Development Table 90. Amgen Company Information Table 91. Amgen Business Overview Table 92. Amgen Gene Delivery System Technology Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. Amgen Gene Delivery System Technology Drug Product Portfolio Table 94. Amgen Recent Development Table 95. Biogen Company Information Table 96. Biogen Business Overview Table 97. Biogen Gene Delivery System Technology Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 98. Biogen Gene Delivery System Technology Drug Product Portfolio Table 99. Biogen Recent Development Table 100. Novartis Company Information Table 101. Novartis Business Overview Table 102. Novartis Gene Delivery System Technology Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 103. Novartis Gene Delivery System Technology Drug Product Portfolio Table 104. Novartis Recent Development Table 105. North America Gene Delivery System Technology Drug Revenue by Type (2021-2026) & (US$ Million) Table 106. North America Gene Delivery System Technology Drug Revenue by Type (2027-2032) & (US$ Million) Table 107. North America Gene Delivery System Technology Drug Revenue by Application (2021-2026) & (US$ Million) Table 108. North America Gene Delivery System Technology Drug Revenue by Application (2027-2032) & (US$ Million) Table 109. North America Gene Delivery System Technology Drug Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 110. North America Gene Delivery System Technology Drug Revenue by Country (2021-2026) & (US$ Million) Table 111. North America Gene Delivery System Technology Drug Revenue by Country (US$ Million) & (2027-2032) Table 112. Europe Gene Delivery System Technology Drug Revenue by Type (2021-2026) & (US$ Million) Table 113. Europe Gene Delivery System Technology Drug Revenue by Type (2027-2032) & (US$ Million) Table 114. Europe Gene Delivery System Technology Drug Revenue by Application (2021-2026) & (US$ Million) Table 115. Europe Gene Delivery System Technology Drug Revenue by Application (2027-2032) & (US$ Million) Table 116. Europe Gene Delivery System Technology Drug Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 117. Europe Gene Delivery System Technology Drug Revenue by Country (2021-2026) & (US$ Million) Table 118. Europe Gene Delivery System Technology Drug Revenue by Country (US$ Million) & (2027-2032) Table 119. China Gene Delivery System Technology Drug Revenue by Type (2021-2026) & (US$ Million) Table 120. China Gene Delivery System Technology Drug Revenue by Type (2027-2032) & (US$ Million) Table 121. China Gene Delivery System Technology Drug Revenue by Application (2021-2026) & (US$ Million) Table 122. China Gene Delivery System Technology Drug Revenue by Application (2027-2032) & (US$ Million) Table 123. Asia Gene Delivery System Technology Drug Revenue by Type (2021-2026) & (US$ Million) Table 124. Asia Gene Delivery System Technology Drug Revenue by Type (2027-2032) & (US$ Million) Table 125. Asia Gene Delivery System Technology Drug Revenue by Application (2021-2026) & (US$ Million) Table 126. Asia Gene Delivery System Technology Drug Revenue by Application (2027-2032) & (US$ Million) Table 127. Asia Gene Delivery System Technology Drug Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 128. Asia Gene Delivery System Technology Drug Revenue by Region (US$ Million) & (2021-2026) Table 129. Asia Gene Delivery System Technology Drug Revenue by Region (US$ Million) & (2027-2032) Table 130. SAMEA Gene Delivery System Technology Drug Revenue by Type (2021-2026) & (US$ Million) Table 131. SAMEA Gene Delivery System Technology Drug Revenue by Type (2027-2032) & (US$ Million) Table 132. SAMEA Gene Delivery System Technology Drug Revenue by Application (2021-2026) & (US$ Million) Table 133. SAMEA Gene Delivery System Technology Drug Revenue by Application (2027-2032) & (US$ Million) Table 134. SAMEA Gene Delivery System Technology Drug Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 135. SAMEA Gene Delivery System Technology Drug Revenue by Country (2021-2026) & (US$ Million) Table 136. SAMEA Gene Delivery System Technology Drug Revenue by Country (US$ Million) & (2027-2032) Table 137. Research Programs/Design for This Report Table 138. Authors List of This Report Table 139. Secondary Sources Table 140. Primary Sources List of Figures Figure 1. Gene Delivery System Technology Drug Image Figure 2. Global Gene Delivery System Technology Drug Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Gene Delivery System Technology Drug Market Size Share 2021 VS 2025 VS 2032 Figure 4. Viral Gene Delivery System Image Figure 5. Non-viral Gene Delivery System Image Figure 6. Global Gene Delivery System Technology Drug Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Gene Delivery System Technology Drug Market Size Share 2021 VS 2025 VS 2032 Figure 8. Neurological Diseases Image Figure 9. Cancer Image Figure 10. Other Image Figure 11. Global Gene Delivery System Technology Drug Market Size (US$ Million) & (2021-2032) Figure 12. Global Gene Delivery System Technology Drug Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Gene Delivery System Technology Drug Market Share by Region: 2021 VS 2025 VS 2032 Figure 14. Global Gene Delivery System Technology Drug Players Revenue Share Top 10 and Top 5 in 2025 Figure 15. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 16. Global Gene Delivery System Technology Drug Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Gene Delivery System Technology Drug Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Gene Delivery System Technology Drug Revenue Market Share by Type (2021-2032) Figure 19. Global Gene Delivery System Technology Drug Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Gene Delivery System Technology Drug Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 21. Global Gene Delivery System Technology Drug Revenue Market Share by Application (2021-2032) Figure 22. North America Gene Delivery System Technology Drug Revenue YoY Growth (2021-2032) & (US$ Million) Figure 23. North America Gene Delivery System Technology Drug Revenue Share by Type (2021-2032) Figure 24. North America Gene Delivery System Technology Drug Revenue Share by Application (2021-2032) Figure 25. North America Gene Delivery System Technology Drug Revenue Share by Country (2021-2032) Figure 26. United States Gene Delivery System Technology Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 27. Canada Gene Delivery System Technology Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Mexico Gene Delivery System Technology Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Europe Gene Delivery System Technology Drug Revenue YoY Growth (2021-2032) & (US$ Million) Figure 30. Europe Gene Delivery System Technology Drug Revenue Share by Type (2021-2032) Figure 31. Europe Gene Delivery System Technology Drug Revenue Share by Application (2021-2032) Figure 32. Europe Gene Delivery System Technology Drug Revenue Share by Country (2021-2032) Figure 33. Germany Gene Delivery System Technology Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. France Gene Delivery System Technology Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. U.K. Gene Delivery System Technology Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Italy Gene Delivery System Technology Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Spain Gene Delivery System Technology Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Russia Gene Delivery System Technology Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Netherlands Gene Delivery System Technology Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Nordic Countries Gene Delivery System Technology Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. China Gene Delivery System Technology Drug Revenue YoY Growth (2021-2032) & (US$ Million) Figure 42. China Gene Delivery System Technology Drug Revenue Share by Type (2021-2032) Figure 43. China Gene Delivery System Technology Drug Revenue Share by Application (2021-2032) Figure 44. Asia Gene Delivery System Technology Drug Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. Asia Gene Delivery System Technology Drug Revenue Share by Type (2021-2032) Figure 46. Asia Gene Delivery System Technology Drug Revenue Share by Application (2021-2032) Figure 47. Asia Gene Delivery System Technology Drug Revenue Share by Region (2021-2032) Figure 48. Japan Gene Delivery System Technology Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 49. South Korea Gene Delivery System Technology Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. India Gene Delivery System Technology Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. Australia Gene Delivery System Technology Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Taiwan Gene Delivery System Technology Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Southeast Asia Gene Delivery System Technology Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. SAMEA Gene Delivery System Technology Drug Revenue YoY Growth (2021-2032) & (US$ Million) Figure 55. SAMEA Gene Delivery System Technology Drug Revenue Share by Type (2021-2032) Figure 56. SAMEA Gene Delivery System Technology Drug Revenue Share by Application (2021-2032) Figure 57. SAMEA Gene Delivery System Technology Drug Revenue Share by Country (2021-2032) Figure 58. Brazil Gene Delivery System Technology Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Argentina Gene Delivery System Technology Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Chile Gene Delivery System Technology Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Colombia Gene Delivery System Technology Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Peru Gene Delivery System Technology Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Saudi Arabia Gene Delivery System Technology Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Israel Gene Delivery System Technology Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. UAE Gene Delivery System Technology Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Turkey Gene Delivery System Technology Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Iran Gene Delivery System Technology Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Egypt Gene Delivery System Technology Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Viral Gene Delivery System
  • Non-viral Gene Delivery System
Applications
  • Neurological Diseases
  • Cancer
  • Other
Companies covered
  • Akcea Therapeutics
  • Alnylam Pharmaceuticals
  • AnGes
  • bluebird bio
  • Gilead Sciences
  • Human Stem Cells Institute
  • Orchard Therapeutics
  • Sarepta Therapeutics
  • SIBIONO
  • Spark Therapeutics
  • Sunway Biotech
  • Amgen
  • Biogen
  • Novartis

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Gene Delivery System Technology Drug Market by Type
  3. 1.2.1 Global Gene Delivery System Technology Drug Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Viral Gene Delivery System
  5. 1.2.3 Non-viral Gene Delivery System
  6. 1.3 Gene Delivery System Technology Drug Market by Application
  7. 1.3.1 Global Gene Delivery System Technology Drug Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Neurological Diseases
  9. 1.3.3 Cancer
  10. 1.3.4 Other
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Gene Delivery System Technology Drug Market Dynamics
  1. 2.1 Gene Delivery System Technology Drug Industry Trends
  2. 2.2 Gene Delivery System Technology Drug Industry Drivers
  3. 2.3 Gene Delivery System Technology Drug Industry Opportunities and Challenges
  4. 2.4 Gene Delivery System Technology Drug Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Gene Delivery System Technology Drug Market Perspective (2021-2032)
  2. 3.2 Global Gene Delivery System Technology Drug Growth Trends by Region
  3. 3.2.1 Global Gene Delivery System Technology Drug Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Gene Delivery System Technology Drug Market Size by Region (2021-2026)
  5. 3.2.3 Global Gene Delivery System Technology Drug Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Gene Delivery System Technology Drug Revenue by Players
  2. 4.1.1 Global Gene Delivery System Technology Drug Revenue by Players (2021-2026)
  3. 4.1.2 Global Gene Delivery System Technology Drug Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Gene Delivery System Technology Drug Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Gene Delivery System Technology Drug Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Gene Delivery System Technology Drug Key Players Headquarters & Area Served
  7. 4.4 Global Gene Delivery System Technology Drug Players, Product Type & Application
  8. 4.5 Global Gene Delivery System Technology Drug Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Gene Delivery System Technology Drug Market CR5 and HHI
  11. 4.6.3 2025 Gene Delivery System Technology Drug Tier 1, Tier 2, and Tier 3
5 Gene Delivery System Technology Drug Market Size by Type
  1. 5.1 Global Gene Delivery System Technology Drug Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Gene Delivery System Technology Drug Revenue by Type (2021-2032)
  3. 5.3 Global Gene Delivery System Technology Drug Revenue Market Share by Type (2021-2032)
6 Gene Delivery System Technology Drug Market Size by Application
  1. 6.1 Global Gene Delivery System Technology Drug Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Gene Delivery System Technology Drug Revenue by Application (2021-2032)
  3. 6.3 Global Gene Delivery System Technology Drug Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Akcea Therapeutics
  2. 7.1.1 Akcea Therapeutics Company Information
  3. 7.1.2 Akcea Therapeutics Business Overview
  4. 7.1.3 Akcea Therapeutics Gene Delivery System Technology Drug Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Akcea Therapeutics Gene Delivery System Technology Drug Product Portfolio
  6. 7.1.5 Akcea Therapeutics Recent Developments
  7. 7.2 Alnylam Pharmaceuticals
  8. 7.2.1 Alnylam Pharmaceuticals Company Information
  9. 7.2.2 Alnylam Pharmaceuticals Business Overview
  10. 7.2.3 Alnylam Pharmaceuticals Gene Delivery System Technology Drug Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Alnylam Pharmaceuticals Gene Delivery System Technology Drug Product Portfolio
  12. 7.2.5 Alnylam Pharmaceuticals Recent Developments
  13. 7.3 AnGes
  14. 7.3.1 AnGes Company Information
  15. 7.3.2 AnGes Business Overview
  16. 7.3.3 AnGes Gene Delivery System Technology Drug Revenue and Gross Margin (2021-2026)
  17. 7.3.4 AnGes Gene Delivery System Technology Drug Product Portfolio
  18. 7.3.5 AnGes Recent Developments
  19. 7.4 bluebird bio
  20. 7.4.1 bluebird bio Company Information
  21. 7.4.2 bluebird bio Business Overview
  22. 7.4.3 bluebird bio Gene Delivery System Technology Drug Revenue and Gross Margin (2021-2026)
  23. 7.4.4 bluebird bio Gene Delivery System Technology Drug Product Portfolio
  24. 7.4.5 bluebird bio Recent Developments
  25. 7.5 Gilead Sciences
  26. 7.5.1 Gilead Sciences Company Information
  27. 7.5.2 Gilead Sciences Business Overview
  28. 7.5.3 Gilead Sciences Gene Delivery System Technology Drug Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Gilead Sciences Gene Delivery System Technology Drug Product Portfolio
  30. 7.5.5 Gilead Sciences Recent Developments
  31. 7.6 Human Stem Cells Institute
  32. 7.6.1 Human Stem Cells Institute Company Information
  33. 7.6.2 Human Stem Cells Institute Business Overview
  34. 7.6.3 Human Stem Cells Institute Gene Delivery System Technology Drug Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Human Stem Cells Institute Gene Delivery System Technology Drug Product Portfolio
  36. 7.6.5 Human Stem Cells Institute Recent Developments
  37. 7.7 Orchard Therapeutics
  38. 7.7.1 Orchard Therapeutics Company Information
  39. 7.7.2 Orchard Therapeutics Business Overview
  40. 7.7.3 Orchard Therapeutics Gene Delivery System Technology Drug Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Orchard Therapeutics Gene Delivery System Technology Drug Product Portfolio
  42. 7.7.5 Orchard Therapeutics Recent Developments
  43. 7.8 Sarepta Therapeutics
  44. 7.8.1 Sarepta Therapeutics Company Information
  45. 7.8.2 Sarepta Therapeutics Business Overview
  46. 7.8.3 Sarepta Therapeutics Gene Delivery System Technology Drug Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Sarepta Therapeutics Gene Delivery System Technology Drug Product Portfolio
  48. 7.8.5 Sarepta Therapeutics Recent Developments
  49. 7.9 SIBIONO
  50. 7.9.1 SIBIONO Company Information
  51. 7.9.2 SIBIONO Business Overview
  52. 7.9.3 SIBIONO Gene Delivery System Technology Drug Revenue and Gross Margin (2021-2026)
  53. 7.9.4 SIBIONO Gene Delivery System Technology Drug Product Portfolio
  54. 7.9.5 SIBIONO Recent Developments
  55. 7.10 Spark Therapeutics
  56. 7.10.1 Spark Therapeutics Company Information
  57. 7.10.2 Spark Therapeutics Business Overview
  58. 7.10.3 Spark Therapeutics Gene Delivery System Technology Drug Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Spark Therapeutics Gene Delivery System Technology Drug Product Portfolio
  60. 7.10.5 Spark Therapeutics Recent Developments
  61. 7.11 Sunway Biotech
  62. 7.11.1 Sunway Biotech Company Information
  63. 7.11.2 Sunway Biotech Business Overview
  64. 7.11.3 Sunway Biotech Gene Delivery System Technology Drug Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Sunway Biotech Gene Delivery System Technology Drug Product Portfolio
  66. 7.11.5 Sunway Biotech Recent Developments
  67. 7.12 Amgen
  68. 7.12.1 Amgen Company Information
  69. 7.12.2 Amgen Business Overview
  70. 7.12.3 Amgen Gene Delivery System Technology Drug Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Amgen Gene Delivery System Technology Drug Product Portfolio
  72. 7.12.5 Amgen Recent Developments
  73. 7.13 Biogen
  74. 7.13.1 Biogen Company Information
  75. 7.13.2 Biogen Business Overview
  76. 7.13.3 Biogen Gene Delivery System Technology Drug Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Biogen Gene Delivery System Technology Drug Product Portfolio
  78. 7.13.5 Biogen Recent Developments
  79. 7.14 Novartis
  80. 7.14.1 Novartis Company Information
  81. 7.14.2 Novartis Business Overview
  82. 7.14.3 Novartis Gene Delivery System Technology Drug Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Novartis Gene Delivery System Technology Drug Product Portfolio
  84. 7.14.5 Novartis Recent Developments
8 North America
  1. 8.1 North America Gene Delivery System Technology Drug Revenue (2021-2032)
  2. 8.2 North America Gene Delivery System Technology Drug Revenue by Type (2021-2032)
  3. 8.2.1 North America Gene Delivery System Technology Drug Revenue by Type (2021-2026)
  4. 8.2.2 North America Gene Delivery System Technology Drug Revenue by Type (2027-2032)
  5. 8.3 North America Gene Delivery System Technology Drug Revenue Share by Type (2021-2032)
  6. 8.4 North America Gene Delivery System Technology Drug Revenue by Application (2021-2032)
  7. 8.4.1 North America Gene Delivery System Technology Drug Revenue by Application (2021-2026)
  8. 8.4.2 North America Gene Delivery System Technology Drug Revenue by Application (2027-2032)
  9. 8.5 North America Gene Delivery System Technology Drug Revenue Share by Application (2021-2032)
  10. 8.6 North America Gene Delivery System Technology Drug Revenue by Country
  11. 8.6.1 North America Gene Delivery System Technology Drug Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Gene Delivery System Technology Drug Revenue by Country (2021-2026)
  13. 8.6.3 North America Gene Delivery System Technology Drug Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
9 Europe
  1. 9.1 Europe Gene Delivery System Technology Drug Revenue (2021-2032)
  2. 9.2 Europe Gene Delivery System Technology Drug Revenue by Type (2021-2032)
  3. 9.2.1 Europe Gene Delivery System Technology Drug Revenue by Type (2021-2026)
  4. 9.2.2 Europe Gene Delivery System Technology Drug Revenue by Type (2027-2032)
  5. 9.3 Europe Gene Delivery System Technology Drug Revenue Share by Type (2021-2032)
  6. 9.4 Europe Gene Delivery System Technology Drug Revenue by Application (2021-2032)
  7. 9.4.1 Europe Gene Delivery System Technology Drug Revenue by Application (2021-2026)
  8. 9.4.2 Europe Gene Delivery System Technology Drug Revenue by Application (2027-2032)
  9. 9.5 Europe Gene Delivery System Technology Drug Revenue Share by Application (2021-2032)
  10. 9.6 Europe Gene Delivery System Technology Drug Revenue by Country
  11. 9.6.1 Europe Gene Delivery System Technology Drug Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Gene Delivery System Technology Drug Revenue by Country (2021-2026)
  13. 9.6.3 Europe Gene Delivery System Technology Drug Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Netherlands
10 China
  1. 10.1 China Gene Delivery System Technology Drug Revenue (2021-2032)
  2. 10.2 China Gene Delivery System Technology Drug Revenue by Type (2021-2032)
  3. 10.2.1 China Gene Delivery System Technology Drug Revenue by Type (2021-2026)
  4. 10.2.2 China Gene Delivery System Technology Drug Revenue by Type (2027-2032)
  5. 10.3 China Gene Delivery System Technology Drug Revenue Share by Type (2021-2032)
  6. 10.4 China Gene Delivery System Technology Drug Revenue by Application (2021-2032)
  7. 10.4.1 China Gene Delivery System Technology Drug Revenue by Application (2021-2026)
  8. 10.4.2 China Gene Delivery System Technology Drug Revenue by Application (2027-2032)
  9. 10.5 China Gene Delivery System Technology Drug Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Gene Delivery System Technology Drug Revenue (2021-2032)
  2. 11.2 Asia Gene Delivery System Technology Drug Revenue by Type (2021-2032)
  3. 11.2.1 Asia Gene Delivery System Technology Drug Revenue by Type (2021-2026)
  4. 11.2.2 Asia Gene Delivery System Technology Drug Revenue by Type (2027-2032)
  5. 11.3 Asia Gene Delivery System Technology Drug Revenue Share by Type (2021-2032)
  6. 11.4 Asia Gene Delivery System Technology Drug Revenue by Application (2021-2032)
  7. 11.4.1 Asia Gene Delivery System Technology Drug Revenue by Application (2021-2026)
  8. 11.4.2 Asia Gene Delivery System Technology Drug Revenue by Application (2027-2032)
  9. 11.5 Asia Gene Delivery System Technology Drug Revenue Share by Application (2021-2032)
  10. 11.6 Asia Gene Delivery System Technology Drug Revenue by Country
  11. 11.6.1 Asia Gene Delivery System Technology Drug Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Gene Delivery System Technology Drug Revenue by Country (2021-2026)
  13. 11.6.3 Asia Gene Delivery System Technology Drug Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Gene Delivery System Technology Drug Revenue (2021-2032)
  2. 12.2 SAMEA Gene Delivery System Technology Drug Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Gene Delivery System Technology Drug Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Gene Delivery System Technology Drug Revenue by Type (2027-2032)
  5. 12.3 SAMEA Gene Delivery System Technology Drug Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Gene Delivery System Technology Drug Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Gene Delivery System Technology Drug Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Gene Delivery System Technology Drug Revenue by Application (2027-2032)
  9. 12.5 SAMEA Gene Delivery System Technology Drug Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Gene Delivery System Technology Drug Revenue by Country
  11. 12.6.1 SAMEA Gene Delivery System Technology Drug Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Gene Delivery System Technology Drug Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Gene Delivery System Technology Drug Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst